Recherche
-
Repeated Piperacillin-Tazobactam Plasma Concentration Measurements in Severely Obese Versus Nonobese Critically Ill Septic Patients and The Risk of Under and Overdosing.
(Crit Care Med. vol. 45, n° 5, pp. e–470–e478, 2017-02)Article de revueLibre accès -
Intérêt du lien ville-hôpital lors de la dispensation en rétrocession de traitements innovants : exemple du Sacubitril/Valsartan.
(Le Pharmacien Hospitalier et Clinicien. vol. 2, n° 52, pp. 367–376, 2017)Article de revue -
Higher than standard dosing regimen are needed to achieve optimal antibiotic exposure in critically ill patients with augmented renal clearance receiving piperacillin-tazobactam administered by continuous infusion
(Journal of Critical Care. vol. 48, pp. 66–71, 2018)Article de revue -
Are Standard Dosing Regimens of Ceftriaxone Adapted for Critically Ill Patients with Augmented Creatinine Clearance?
(Antimicrobial Agents and Chemotherapy. vol. 63, n° 3, pp. e02134–18, 2019-01)Article de revueAccès réservé